Insider Trading & Ownership of Paul B. Manning

Location: Charlottesville, VA
Summary: The estimated net worth of Paul B. Manning is at least $141,804,165 dollars as of 25 Nov 2025. Paul B. Manning is the Director of Liquidia Corp and owns shares of Liquidia Corp (LQDA) stock worth about $72,872,679. Paul B. Manning is the Director, 10%+ Owner of Verrica Pharmaceuticals Inc. and owns shares of Verrica Pharmaceuticals Inc. (VRCA) stock worth about $32,171,572. Paul B. Manning is the Director of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $26,661,625. Paul B. Manning is the 10%+ Owner of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $7,814,686. Paul B. Manning is the 10%+ Owner of Acumen Pharmaceuticals, Inc. and owns shares of Acumen Pharmaceuticals, Inc. (ABOS) stock worth about $2,283,603.
Signature: /s/ Mark Ballantyne, Attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Paul B. Manning files a new Insider Trading report.

Ownership of Paul B. Manning

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
LQDA	Liquidia Corp	Director	$72,872,679	-$18,957,475	-20.6%	28 Aug 2025
VRCA	Verrica Pharmaceuticals Inc.	Director, 10%+ Owner	$32,171,572	+$17,505,157	+1.2%	25 Nov 2025
CADL	Candel Therapeutics, Inc.	Director	$26,661,625			25 Jun 2025
TSHA	Taysha Gene Therapies, Inc.	10%+ Owner	$7,814,686	+$2,062,500	+35.9%	30 May 2025
ABOS	Acumen Pharmaceuticals, Inc.	10%+ Owner	$2,283,603			06 Jul 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.